Complement-induced endothelial dysfunction in rabbits: Mechanisms, recovery, and gender differences

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 6 39-6, 1996, Pages

  Lennon, Paul F ^a   Collard, Charles D ^a   Morrissey, Margaret A ^a   Stahl, Gregory L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

A23187; acetylcholine; C5b 9; complement inhibition; reactive oxygen species

Indexed keywords

ACETYLCHOLINE; CALCIMYCIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEX DIFFERENCE; THORACIC AORTA; VASCULAR RING; VASODILATATION;

EID: 33750812290     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.6.h1924     Document Type: Article

References (36)

1. Amsterdam, E. A., G. L. Stahl, H. L. Pan, S. V. Rendig, M. P. Fletcher, and J. C. Longhurst. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H448-H457, 1995.
2. Böttiger, B. W., J. Motsch, T. Böker, E. Martin, and M. Kirschfink. Marked activation of complement and blood coagulation following cardiac arrest and during resuscitation in man (Abstract). Anesthesiology 81: A348, 1994.
3. Brooimans, R. A., P. A. M. van Wieringen, L. A. van Es, and M. R. Daha. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Eur. J. Immunol. 22: 3135-3140, 1992.
4. Buerke, M., T. Murohara, and A. M. Lefer. Cardioprotective effects of a Cl esterase inhibitor in myocardial ischemia and reperfusion. Circulation 91: 393-402, 1995.
5. Chenoweth, D. E. The properties of human C5a anaphylatoxin. Contrib. Nephrol. 59: 51-71, 1987.
6. Crawford, M. H., F. L. Grover, W. P. Kolb, C. A. McMahan, R. A. O'Rourke, L. M. McManus, and R. N. Pinckard. Complement and netatrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 78: 1449-1458, 1988.
7. Davenpeck, K. L., T. W. Gauthier, and A. M. Lefer. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 107: 1050-1058, 1994.
8. Friedl, H. P., G. O. Till, U. S. Ryan, and P. A. Ward. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J. 3: 2512-2518, 1989.
9. Furchgott, R. F., and J. V. Zawadski. The obligatory role of endothelial cells on the relaxation of arterial smooth muscle by acetylcholine. Nature Lond. 288: 373-376, 1980.
10. Garvery, J. S., N. E. Cremer, and D. H. Sussdorf. Methods in Immunology (3rd ed). Reading, MA: Benjamin Cummings, 1977, pp. 379-387.
11. Gryglewski, R. J., R. M. J. Palmer, and S. Moncada. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature Lond. 320: 454-456, 1986.
12. Halperin, J. A., A. Taratuska, M. Rynkiewicz, and A. Nicholson-Weller. Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9). Blood 81: 200-205, 1993.
13. Homeister, J. W., P. Satoh, and B. R. Lucchesi. Effects of complement activation in the isolated heart. Role of the terminal complement components. Circ. Res. 71: 303-319, 1992.
14. Keany, J. F., G. T. Shwaery, A. Xu, R. J. Nicolosi, J. Loscalzo, T. L. Foxall, and J. A. Vita. 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 89: 2251-2259, 1994.
15. Kilgore, K. S., G. S. Friedrichs, J. W. Homeister, and B. R. Lucchesi. The complement system in myocardial ischaemia/ reperfusion injury. Cardiovasc. Res. 28: 437-444, 1994.
16. Kirklin, J. K., S. Westaby, E. H. Blackstone, J. W. Kirlin, D. E. Chenoweth, and A. D. Pacifico. Complement and the damaging effects of cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 86: 845-857, 1983.
17. Mehta, J. L., W. W. Nichols, and P. Mehta. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J. Am. Coll. Cardiol. 11: 1309-1316, 1988.
18. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
19. Morgan, B. P., J. R. Dankert, and A. F. Esser. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J. Immunol. 138: 246-253, 1987.
20. Morgan, B. P. Complement membrane attack on nucleated cells: resistance, recovery, and non-lethal effects. Biochem. J. 264: 1-14, 1989.
21. Morgan, P. B., and S. Meri. Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 15: 369-396, 1994.
22. Mullane, K. M., N. Read, J. A. Salmon, and S. Moncada. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 228: 510-522, 1984.
23. Ramm, L. E., M. B. Whitlow, C. L. Koski, M. L. Shin, and M. M. Mayer. Elimination of complement channels from the plasma membranes of U937, a nucleated mammalian cell line: temperature dependence of the elimination rate. J. Immunol. 131: 1411-1415, 1983.
24. Rus, H. G., F. Niculescu, D. Porutiu, V. Ghiurca, and R. Vlaicu. Cells carrying C5b-9 complement complexes in human atherosclerotic wall. Immunol. Lett. 20: 305-310, 1989.
25. Seesney, S. M., S. C. Makrides, M. L. Gosselin, P. J. Ford, B. M. Andrews, E. G. Hayman, and H. C. Marsh. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway (Abstract). FASEB J. 9: A807, 1995.
26. Stahl, G. L., and A. M. Lefer. Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. Blood Vessels 24: 24-30, 1987.
27. Stahl, G. L., W. R. Reenstra, and G. Frendl. Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries: role of the terminal membrane attack complex. Circ. Res. 76: 575-583, 1995.
28. Stander, J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936, 1994.
29. Tsao, P. S., N. Aoki, D. J. Lefer, G. Johnson, and A. M. Lefer. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82: 1402-1412, 1990.
30. Tschopp, J. Ultrastructure of the membrane attack complex of complement. J Biol. Chem. 259: 7857-7863, 1984.
31. Unsworth, D. J., R. Würzner, D. L. Brown, and P. J. Lachmann. Extracts of wheat gluten activate complement via the alternative pathway. Clin. Exp. Immunol. 94: 539-543, 1993.
32. Unthank, J. L., J. G. Nixon, and M. C. Dalsing. Acute compensation to abrupt occlusion of rat femoral artery is prevented by NO synthase inhibitors. Am. J. Physiol. 267 (Heart Circ. Physiol 37): H2523-H2530, 1994.
33. Weisman, H. F., T. Bartow, M. K. Leppo, H. C. Marsh, G. R. Carson, M. F. Concino, M. P. Boyle, K. H. Roux, M. L. Weisfeldt, and D. T. Fearon. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science Wash. DC 249: 146-151, 1990.
34. Williams, J. K., M. R. Adams, D. M. Herrington, and T. B. Clarkson. Short-term administration of estrogen and vascular response of atherosclerotic coronary arteries. J. Am. Coll. Cardial. 20: 452-457, 1992.
35. Wolin, M. S., and F. L. Belloni. Superoxide anion selectively attenuates catecholamine-induced contractile tension in isolated rabbit aorta. Am. J. Physiol. 249 (Heart Circ. Physiol. 18): H1127-H1133, 1985.
36. Yue, P., K. Chatterjee, C. Beale, P. A. Poole-Wilson, and P. Collins. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91: 1154-1160, 1995.